The prescription drug named Tavneos has been recalled from pharmacies after the European Commission revoked its marketing authorization due to serious irregularities encountered during clinical trials. (translated)
The drug named Tavneos has been immediately banned in Hungary, and authorities have warned patients not to stop taking the medication on their own, but to consult their treating physician for alternative therapy. (translated)
The drug Tavneos, used to treat rare autoimmune diseases, has been withdrawn from the market in France due to its deemed too high risk, after several reported deaths abroad due to serious side effects. (translated)
The drug Tavneos, used to treat certain rare autoimmune diseases, has been removed from the French market due to a risk/benefit report deemed unfavorable after reports of deaths related to serious side effects, prompting patients not to discontinue their treatment without an alternative. (translated)
The French National Agency for Medicines (ANSM) announced the withdrawal of the drug Tavneos from the French market, used to treat certain autoimmune diseases, following reports of deaths abroad. (translated)
Europeiska läkemedelsmyndigheten (EMA) rekommenderar att marknadsföringstillståndet för läkemedlet Tavneos (avakopan) återkallas eftersom nytta inte längre bedöms överväga riskerna, vilket har framkommit efter att de data som låg till grund för godkännandet visat sig vara felaktiga och otillförlitliga. #Tavneos #avakopan #läkemedel
Συναγερμός έχει σημάνει στην Ιαπωνία λόγω αναφορών για 20 θανάτους ασθενών που έλαβαν το φάρμακο Tavneos της Amgen, το οποίο σχετίζεται με σοβαρή ηπατική δυσλειτουργία, γεγονός που έχει οδήγησε την εταιρεία Kissei Pharmaceutical να προειδοποιήσει τους γιατρούς να σταματήσουν τη χορήγηση του σε νέους ασθενείς. #Tavneos #ηπατικήβλάβη #ΙΑΤΡΙΚΑΘΕΜΑΤΑ
Συναγερμός έχει σημάνει στην Ιαπωνία μετά από αναφορές για 20 θανάτους ασθενών που έλαβαν το φάρμακο Tavneos της Amgen, το οποίο σχετίζεται με σοβαρή ηπατική δυσλειτουργία, ενώ η Kissei Pharmaceutical προειδοποίησε τους γιατρούς να σταματήσουν τη χορήγηση του σε νέους ασθενείς και να επανεξετάσουν τις τρέχουσες θεραπείες. #Tavneos #ηπατικήβλάβη #Ιαπωνία
Compania farmaceutică japoneză Kissei a cerut oprirea prescrierii medicamentului Tavneos, destinat tratamentului bolilor autoimune rare, după ce 20 de pacienți au decedat de la lansarea acestuia în Japonia. #medicamente #japonia #decese
Medicul Japonez a suspendat prescrierea medicamentului Tavneos după ce 20 de persoane au murit, având suspiciuni că pastilele ar putea cauza afecțiuni grave, în timp ce tratamentul este autorizat și în România, unde medicii pot continua să-l prescrie pacienților deja tratați. #Tavneos #medicamente #Japonia
